NCT07184463 A Study of Pain Reduction After Pulmonary Resection by RATS-TT, RATS-OTC, and Hybrid RATS.
| NCT ID | NCT07184463 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) |
| Condition | Thoracic Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-12-05 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-12-05 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pulmonary resections are key in treating lung neoplasms, with techniques adapted to tumor size and location. Minimally invasive approaches like VATS have replaced open thoracotomy, but intercostal trocar placement can lead to nerve injury and chronic pain. Robotic-assisted thoracic surgery (RATS) is usually done via a transthoracic (RATS-TT) approach using intercostal trocars. A newer "out of cage" method (RATS-OTC), using subcostal or subxiphoid ports, avoids intercostal access, potentially reducing nerve damage. A French study showed less opioid use and acute pain with RATS-OTC, but chronic pain outcomes are still unknown. At CHUM, a hybrid RATS technique (RATS-TTH) is also used-intercostal for instruments, but with out-of-cage specimen extraction-to limit intercostal trauma.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years and older * American Society of Anesthesiologists (ASA) score 1-3 Exclusion Criteria: * Language barrier, psychiatric, physical or mental condition making pain assessment impossible despite prior education * Patient refusal to participate * Patients reoperated by VATS or thoracotomy in the postoperative period in the context of the occurrence of complications
Contact & Investigator
Alex Moore, MD
PRINCIPAL INVESTIGATOR
CHUM
Frequently Asked Questions
Who can join the NCT07184463 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thoracic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07184463 currently recruiting?
Yes, NCT07184463 is actively recruiting participants. Contact the research team at alex.moore.med@ssss.gouv.qc.ca for enrollment information.
Where is the NCT07184463 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT07184463 clinical trial?
NCT07184463 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM). The principal investigator is Alex Moore, MD at CHUM. The trial plans to enroll 120 participants.